Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Cheila Eickhoff"'
Autor:
Laura Fogliatto, Marcelo Capra, Mariza Shaan, Tito Vanelli Costa, Raquel Breunig, Christina G S Fraga, Mayde Seadi Torriani, Lucia Silla, Liane Esteves Daudt, Mario Sérgio Fernandes, Denise Almeida, Marco Antônio Schilling, Tânia Hellwig, Katia Fassina, Sabrina Wisintainer, Mariangela Moschen, Tiago Daltoe, Adriana Zardo, Juliana Kratochvil, Viviane Magagnin Fernandes, Cheila Eickhoff, Moema Nene, Saozan Ahmad, Andréia Dias Almeida, Vitor Lenz
Publikováno v:
Blood. 122:5176-5176
Background Treatment of chronic myeloid leukemia with imatinib leads to disease remission in a majority of patients (pts), but in a subgroup of pts controlling the disease remains a challenge. One of the proposed prognostic factors for identifying th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a0bcb08be63425617a1ab25380bece8
https://doi.org/10.1182/blood.v122.21.5176.5176
https://doi.org/10.1182/blood.v122.21.5176.5176
Autor:
Saozan Ahmad, Sabrina Wisintainer, Viviane Magagnin Fernandes, Mariangela Moschen, Moema Nene, Mariza Shaan, Mario Sérgio Fernandes, Tito Vanelli Costa, Tiago Daltoe, Laura Fogliatto, Marco Antônio Schilling, Juliana Kratochvil, Cheila Eickhoff, Andréia Dias Almeida, Tânia Hellwig, Marcelo Capra, Adriana Zardo, Virginia Maria Coser, Márcia Leite, Lucia Mariano da Rocha Silla, Dayane Bohn Koshiyama, Denise Almeida, Waldir Veiga Pereira, Katia Fassina, Liane Esteves Daudt, Nathália Guterres Xavier, Dalnei Veiga Pereira, Vitor Lenz, Mayde Seadi Torriani
Publikováno v:
Blood. 118:4423-4423
Abstract 4423 Background Treatment of chronic myeloid leukemia with imatinib leads to disease remission in a majority of patient, but in some patients (pts) controlling the disease remains a challenge. One of the proposed prognostic factors for ident
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c7e7b2ed6e88ea21230d2eb7938cc2f
https://doi.org/10.1182/blood.v118.21.4423.4423
https://doi.org/10.1182/blood.v118.21.4423.4423
Autor:
Mayde Seadi Torriani, Liane Esteves Daudt, Mariza Shaan, Tânia Hellwig, Virginia Maria Coser, Dalnei Veiga Pereira, Andréia Dias Almeida, Saozan Ahmad, Waldir Veiga Pereira, Adriana Zardo, Denise Almeida, Marco Antônio Schilling, Laura Fogliatto, Mariangela Moschen, Viviane Magagnin Fernandes, Mario Sérgio Fernandes, Lucia Mariano da Rocha Silla, Marcelo Capra, Tito Vanelli Costa, Márcia Leite, Tiago Daltoe, Cheila Eickhoff, Moema Nene, Sabrina Wisintainer, Katia Fassina, Vitor Lenz, Juliana Kratochvil, Dayane Bohn Koshiyama, Nathália Guterres Xavier
Publikováno v:
Blood. 118:4425-4425
Abstract 4425 Adherence to imatinib therapy has proven to be a major determinant of treatment results, but the degree of impact and the determinants of nonadherence are still contradictory. There is no information regarding adherence to imatinib ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a89bc53fa3da07c644d95a253ed916f
https://doi.org/10.1182/blood.v118.21.4425.4425
https://doi.org/10.1182/blood.v118.21.4425.4425